A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans
Researchers evaluated the safety and efficacy of bone marrow-derived mononuclear cell implantation in critical limb-threatening ischemia patients with thromboangiitis obliterans.